Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Agilon Health ( (AGL) ) has shared an announcement.
On March 30, 2026, Agilon Health implemented a 1-for-25 reverse stock split of its issued and outstanding common shares, following shareholder approval at a special meeting held on March 17, 2026. At the effective time, each block of 25 existing shares was automatically converted into one share, with no fractional shares issued and cash paid in lieu, while authorized share count and par value remained unchanged.
The company proportionally adjusted shares available and outstanding under its equity incentive plans, as well as the exercise terms of stock options and other equity-linked securities, ensuring capital structure continuity post-split. Agilon’s stock will begin trading on a split-adjusted basis on the NYSE under the same ticker, AGL, on March 31, 2026, a move that typically aims to boost the per-share trading price and maintain listing standards, with operational impacts focused on share count and investor holdings rather than core business activities.
The most recent analyst rating on (AGL) stock is a Sell with a $0.35 price target. To see the full list of analyst forecasts on Agilon Health stock, see the AGL Stock Forecast page.
Spark’s Take on AGL Stock
According to Spark, TipRanks’ AI Analyst, AGL is a Neutral.
The score is held down primarily by weak financial performance (persistent losses and ongoing cash burn) and a strong bearish technical trend. Partially offsetting these are management’s quantified 2026 turnaround plan and a modest balance-sheet benefit from low leverage, though policy and medical-cost volatility create substantial execution risk.
To see Spark’s full report on AGL stock, click here.
More about Agilon Health
Agilon Health, Inc. operates in the healthcare services industry, focusing on value-based care arrangements for senior patients through partnerships with primary care physician groups. The company’s business model centers on managing healthcare outcomes and costs for Medicare beneficiaries, positioning it within the growing market for risk-based, capitated payment models in U.S. healthcare.
Average Trading Volume: 6,675,121
Technical Sentiment Signal: Sell
Current Market Cap: $164.4M
See more data about AGL stock on TipRanks’ Stock Analysis page.